Ilaris and Amyloidosis senile - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Ilaris?
Ilaris has active ingredients of canakinumab. Currently, eHealthMe is studying from 12,038 Ilaris users.
What is Amyloidosis Senile?
Amyloidosis senile (common form of amyloidosis in very old people, usually mild and limited to the heart) is found to be associated with 17 drugs and 17 conditions by eHealthMe. Currently, we are studying 645 people who have Amyloidosis senile.
Do you take Ilaris and have Amyloidosis senile?Check whether Amyloidosis senile is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Ilaris side effects by duration, gender and age:
- Ilaris side effects (12,038 reports)
Amyloidosis senile treatments and more:
- Amyloidosis senile (645 reports)
All the drugs that are associated with Amyloidosis senile:
All the conditions that are associated with Amyloidosis senile:
How the study uses the data?
The study uses data from the FDA. It is based on canakinumab (the active ingredients of Ilaris) and Ilaris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lorazepam and Rash Vesicular - 8 seconds ago
- H.P. Acthar Gel and Vigabatrin drug interaction - 11 seconds ago
- Prochlorperazine and Pseudomonas Infection - 13 seconds ago
- Hydrochlorothiazide and Vancenase drug interaction - 14 seconds ago
- Dipentum and Simvastatin drug interaction - 15 seconds ago
- Loratadine and Phenergan drug interaction - 16 seconds ago
- Mirena and Hypomenorrhea - 18 seconds ago
- Abraxane and Vagifem drug interaction - 18 seconds ago
- Plan B and Hypomenorrhea - 22 seconds ago
- Hydrocodone Bitartrate And Acetaminophen and Hibiclens drug interaction - 23 seconds ago